takasubo cardiomyopathy

40
TAKATSUBO CARDIOMYOPATHY DR JENU CHAKOLA

Upload: jenu-chakola

Post on 01-Jun-2015

190 views

Category:

Health & Medicine


5 download

DESCRIPTION

A presentation on TAKASUBO CARDIOMYOPATHY

TRANSCRIPT

Page 1: Takasubo cardiomyopathy

TAKATSUBO CARDIOMYOPATHY

DR JENU CHAKOLA

Page 2: Takasubo cardiomyopathy

• Also called “ transient apical ballooning “ and stress cardiomyopathy .

• Is a reversible cardiomyopathy featuring symptoms and signs of acute myocardial infarction without demonstrable coronary artery stenosis or spasm, in which the heart takes on the appearance of a Japanese octopus fishing pot called a ‘takot- subo’ .

Page 3: Takasubo cardiomyopathy
Page 4: Takasubo cardiomyopathy

• It is characterized by transient systolic ventricular dysfunction with regional wall motion abnormalities beyond a single vascular territory and in the absence of significant epicardial coronary artery obstruction.

• Often, there is an acute emotional or physical stressor immediately preceding the presentation. Classical apical ballooning is seen on ventriculography or echo .

Page 5: Takasubo cardiomyopathy

• Catecholamine excess and cardiotoxicity is the most compelling putative mechanism.

• The long-term prognosis is excellent but serious complications including cardiogenic shock and arrhythmias may occur acutely.

• Supportive treatment is the mainstay of therapy.

Page 6: Takasubo cardiomyopathy

• INTRODUCTION :• It is a reversible cardiomyopathy characterized by

transient systolic ventricular dysfunction with a clinical presentation indistinguishable from acute myocardial infarction but in the absence of significant coronary artery obstruction .

• Frequently precipitated by sudden , stressful emotional events , but also have been reported

• Following physiologic stress such as sepsis , non cardiac surgery and SAH .

Page 7: Takasubo cardiomyopathy

• This syndrome was reported as early as 1967 in patients under intense emotional stress such as bereavement or after homicidal assault .

• In the 1990s, Sato and colleagues coined the term takotsubo cardiomyopathy to describe the unusual shape of the left ventricular during systole .

• Typically, the mid to apical segments of the left ventricle are akinetic and the spared, basal walls exhibit compensatory hypercontractility.

Page 8: Takasubo cardiomyopathy

• Takotsubo is a pot with round base and narrow neck used in Japan for trapping octopuses and has a similar appearance to this apical ballooning.

• TTC occurs most commonly in post-menopausal women and has a very good prognosis.

• Acutely, patients are often critically ill with heart failure and secondary complications such as LVOT obstruction, and arrhythmias but ventricular dysfunction and symptoms resolve quickly and death is very rare.

Page 9: Takasubo cardiomyopathy

• Epidemology :• On view of the increasing awareness of this

condition, in 2006 the AHA , incorporated TTC into the classification of cardiomyopathies as a primary acquired cardiomyopathy.

• On the basis of recent analyses reported from several countries, this condition probably accounts for 1% to 2% of all cases of suspected acute myocardial infarction .

Page 10: Takasubo cardiomyopathy

• CLINICAL PRESENTATION :• The clinical presentation of TTC is often identical to acute

myocardial infarction (AMI).• Most patients with TTC present with typical anginal chest

pain, dyspnea, ischemic changes on electrocardiogram (ECG), and elevated cardiac markers, where as syncope and out-of-hospital cardiac arrest are rare .

• Emotional stress, such as news of the death of a family member, divorce, or public speaking, is implicated as the trigger in approximately two-thirds of patients .

Page 11: Takasubo cardiomyopathy

• Physical stress such as non cardiac surgery , sepsis or critical illness have also been reported to cause TTC .

• In one provocative prospective study, con- secutive critically ill patients with no prior cardiac history who were admitted to a medical ICU underwent serial echocardiograms; 28% were noted to have transient reduced EF with imaging features consistent with TTC .

Page 12: Takasubo cardiomyopathy

• PATHOPHYSIOLOGY :• Patients with TTC who underwent myocardial

biopsy have shown almost same results:• 1) interstitial infiltrates consisting primarily of

mononuclear lymphocytes, leukocytes, and macrophages;

• 2) myocardial fibrosis; and contraction bands with or without overt myocyte necrosis.

Page 13: Takasubo cardiomyopathy

• The inflammatory changes and contraction bands distinguish takotsubo cardiomyopathy from coagulation necrosis, as seen in myocardial infarction resulting from coronary artery occlusion .

• The exact pathophysiological basis of the distinctive contractile pattern in takotsubo cardiomyopathy remains to be elucidated .

Page 14: Takasubo cardiomyopathy

• A few concepts about the pathophysiology of TTC :

• 1) Multi vessel Epicardial Coronary Spasm• 2) Catecholamine toxicity• 3) Coronary micro vascular impairement• 4) Neurogenic stunned myocardium

Page 15: Takasubo cardiomyopathy

• Multivessel Epicardial Coronary Artery Spasm :• Reversible ventricular dysfunction might result

from epicardial coronary artery spasm and consequently regionally stunned myocardium .

• When no spontaneous coronary spasm has actually been observed, impaired coronary blood flow caused by vulnerable plaque rupture has been proposed as a cause of takotsubo cardiomyopathy .

Page 16: Takasubo cardiomyopathy

• POINTS against this hypothesis :• 1) Multivessel epicardial spasm and regionally

stunned myocardium does not explain the discrepancy between severe apical LV dysfunction and modest increase in cardiac enzymes, and

• 2) after plaque rupture in a single coronary artery, the area of abnormal left ventricular wall motion would not be expected to extend beyond the perfusion territory normally supplied by the artery.

Page 17: Takasubo cardiomyopathy

• 3) ECG findings seem to differ between patients with acute coronary syndrome and those with TTC .

• TTC do not show reciprocal changes, although ECG findings do not have sufficient predictive value to distinguish takotsubo cardiomyopathy from acute coronary syndrome in individual patients .

• 4) Ischemic myocardial stunning does not produce the histological changes usually observed in takotsubo cardiomyopathy .

Page 18: Takasubo cardiomyopathy

• 5) spontaneous or inducible coronary arterial spasm has not been found in most cases of TTC .

• Hence ,myocardial stunning resulting from epicardial coronary artery spasm does not seem to cause TTC .

Page 19: Takasubo cardiomyopathy

• CORONARY MICROVASCULAR IMPAIREMENT :• Another hypothesis on the pathophysiology of TTC .• The abnormal left ventricular wall motion occuring in a

relatively large area of the apical myocardium in patients with takotsubo cardiomyopathy can cause disturbances in the coronary microcirculation .

• Yoshida et al reported impaired coronary perfusion and severe myocardial metabolic abnormalities in patients with takotsubo cardiomyopathy on the basis of results of thallium-201 myocardial single-photon emission CT .

Page 20: Takasubo cardiomyopathy

• This suggest that coronary microcirculatory abnormalities accompanying takotsubo cardiomyopathy may be a result of increased mechanical wall stress as a consequence of apical ballooning .

Page 21: Takasubo cardiomyopathy

• CATECHOLAMINE TOXICITY :• A comparison study which was done by Wittstein et al about the

plasma levels of epinephrine and norepinephrine in patients who were hospitalised for stress cardiomyopathy who had apical ballooning and patients with acute MI .

• The plasma levels of both epinephrine and norepinephrine were remarkably increased in the stress cardiopathy patients suggesting the remarkably elevated catecholamine levels might be the main pathogenetic factor.

• However, elevated catecholamine levels are not uniformly found in all patients with this syndrome .

Page 22: Takasubo cardiomyopathy

• The myocardial histological changes in takotsubo cardiomyopathy strikingly resemble those seen in catecholamine cardiotoxicity .

• These changes, which differ from those in ischemic cardiac necrosis, include contraction band necrosis, neutrophil infiltration, and fibrosis.

• These findings probably reflect consequences of high intracellular concentrations of Ca2, and it has been proposed that Ca2 overload in myocardial cells produces the ventricular dysfunction in catecholamine cardiotoxicity .

Page 23: Takasubo cardiomyopathy

• NEUROGENIC STUNNED MYOCARDIUM :

• The cardiac functional and ECG abnormalities in takotsubo cardiomyopathy might reflect activation of central neurogenic mechanisms similar to that in SAH .

• Intracranial pathology can produce the same myocardial histopathological findings seen in takotsubo cardiomyopathy.

• The basal myocardium has a higher norepinephrine content and greater density of sympathetic nerves than the apical myocardium does and that does not explain the apical ballooning that characterizes takotsubo cardiomyopathy .

Page 24: Takasubo cardiomyopathy

• The left ventricular apex contains a higher concentration of adrenoceptors which causes increased myocardial responsiveness to adrenergic stimulation in the apex .

• Therefore, takotsubo cardiomyopathy may reflect stunned myocardium from a neurogenic source.

• In short , the available pathophysiological information indicates that the apical ballooning that characterizes takotsubo cardiomyopathy reflects toxic high local concentrations of catecholamines, not coronary artery or microvascular disease .

Page 25: Takasubo cardiomyopathy

• The “first cause” would be neurogenic, with the precipitant sudden, unexpected, severe emotional distress .

• In typical apical ballooning, high local concentrations of norepinephrine might evoke basal hyperkinesis, increasing mechanical wall stress at the apex and thereby increasing end-diastolic pressure and BNP levels .

Page 26: Takasubo cardiomyopathy

• ECG AND CARDIAC BIOMARKERS :

• The most common abnormality on the ECG is ST elevation and T-wave inversion in the precordial leads , resembling acute AMI .

• Several ECG criteria have been proposed to differentiate TTC from acute myocardial infarction .

• The absence of q waves, reciprocal changes, ST segment elevation in V1 with sum of ST elevation in V4-6 greater than that in V1-V3 as well as ST depressions in a VR have been shown to discriminate between the two diseases with high sensitivity and specificity .

Page 27: Takasubo cardiomyopathy

• More extensive ST elevation in inferior leads were seen more frequently in TTC compared with AMI .

• Evolutionary changes on ECG often occur two to three days after initial symptoms and presentation, with resolution of ST elevation, followed by diffuse and deep T-wave inversion, prolongation of QT interval.

• Pathologic q waves may be observed initially but rarely persist.

• T-wave inversion and QT-prolongation may persist for three to four months .

Page 28: Takasubo cardiomyopathy

• Modest elevation of cardiac biomarkers is often observed in TTC .

• But the cardiac troponin levels in TTC are much less than that typically observed in acute STEMI and are out of proportions to the extensive wall motion abnormalities and hemodynamic compromise .

• Troponin T levels are typically < 5ng/ml .

Page 29: Takasubo cardiomyopathy

• DIAGNOSIS :• Due to the dramatic clinical presentation and

high suspicion for acute MI , most patients undergo emergent coronary angiography.

• Typical findings in TTC are normal epicardial coronaries, mild non-obstructive atherosclerosis, or rarely coexistent coronary artery disease .

• Therefore, TTC is a diagnosis of exclusion which can only be made after coronary angiography .

Page 30: Takasubo cardiomyopathy

• It should be on the differential diagnosis in any post-menopausal women over 50 years old presenting with chest pain and ischemic ECG changes particularly in the setting of emotional stress.

• Furthermore it should also be considered in critically ill patients with sudden hemodynamic compromise and/or heart failure .

Page 31: Takasubo cardiomyopathy

• CARDIAC IMAGING :• Ventriculography reveals apical ballooning, with

characteristic sparing of the basal segments and akinesis of the mid and apical left ventricle.

• However, variants of this pattern have been described including midventricular ballooning or basal and midventricular akinesis with apical sparing (inverted Takotsubo) .

• In patients with typical TTC, the wall motion abnormality usually extends beyond the distribution of a single coronary artery.

Page 32: Takasubo cardiomyopathy

• Echocardiography can detect and measure the degree of LVOT obstruction and associated systolic motion of the anterior mitral valve ( SAM ) and significant mitral regurgitation.

• LVOT obstruction is reported to occur in 25% patients and can have a major impact on acute management.

• In patients with hemodynamic compromise and shock, inotropes would worsen this situation and B - blockers and pure vasopressor pharmacologic or mechanical support may be needed.

Page 33: Takasubo cardiomyopathy

• Cardiac MRI may reveal the absence of delayed gadolinium hyperenhancement.

• This is specific to TTC and can help differentiate it from myocarditis and acute myocardial infarction in which delayed hyperenhancement is present .

Page 34: Takasubo cardiomyopathy

• PROGNOSIS :• Takotsubo cardiomyopathy has an excellent

prognosis, with full and early recovery in virtually all patients.

• The majority of patients have normalization of LVEF within a week and all patients by 4-8 weeks .

• In-hospital mortality is low (0-8%) ; it may be increased in those with underlying conditions .

• Long-term survival is similar to the general pop- ulation .

Page 35: Takasubo cardiomyopathy

• Although TTC has a favorable prognosis, several acute complications should be anticipated.

• 1) Congestive heart failure is documented in 3-46% ,• 2) hypotension and shock are rare in 4% .• 3) Systemic thromboembolism is reported in 5% .• 4) LVOT obstruction has been seen in 20-25% of

patients , but symptomatic obstruction is uncommon .• 5) Arrhythmias, including atrial fibrillation, are presents

in 10-26% of cases, but fatal arrhythmias such as ventricular fibrillation are rare .

Page 36: Takasubo cardiomyopathy

• MANAGEMENT :• Takotsubo cardiomyopathy is a temporary condition

and hence the goals of treatment are usually conservative, supportive care.

• The therapy is guided by the patient’s clinical presentation and hemodynamic status.

• Despite the supposed causative role of catecholamines in the disorder, patients who present in cardiogenic shock, and in the absence of LVOT obstruction, may be treated with inotropes.

Page 37: Takasubo cardiomyopathy

• Alternatively patients may derive further benefit from mechanical hemodynamic support with intra-aortic balloon pump or rarely, left ventricular assist devices.

• If LVOT obstruction is present with cardiogenic shock, inotropes should be avoided and phenylphrine is the pressor agent of choice often combined with betablockade.

Page 38: Takasubo cardiomyopathy

• Most experts advocate guideline- directed medical therapy for patients with left ventricular dysfunction.

• This includes cardioselective beta-blockers and ACE inhibitor for a short period of time (3-6 months) .

• Full anticoagulation is usually reserved for those with documented ventricular thrombus or evidence of embolic events .

Page 39: Takasubo cardiomyopathy
Page 40: Takasubo cardiomyopathy

THANK YOU